Versameb AG
PrivateLast Round
VC Round
Jul 10, 2023
Total Funding Raised
$18.18M
Company Overview
Versameb AG operates in Healthcare & Life Sciences and is based in Basel. Its latest recorded funding round was a VC Round in July 2023.
Versameb AG is a biotechnology company that discovers and develops innovative RNA-based therapeutics for the modulation of protein expression and cellular targeting.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Versameb AG Comparables
Compare Versameb AG with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Replicate Bioscience | 82% | |
| Eli Lilly and Company | 81% | |
| Strand Therapeutics | 78% |
For institutional investors. Book with your work email.
Versameb AG Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Jul 10, 2023 | ||||
| Seed | Jul 15, 2020 | ||||
| Seed | Oct 17, 2019 | ||||
| Seed | Dec 18, 2018 | ||||
| Grant | Sep 18, 2017 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Versameb AG Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| BaseLaunch | Grant, VC Round, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 15, 2020
$6.37M raised in Seed round.
- Dec 18, 2018
$5.3M round led by BaseLaunch
For institutional investors. Book with your work email.
Versameb AG Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Versameb AG's valuation, stock price, and market status.
Is Versameb AG a public or private company?
Versameb AG is a private company.
What is the current stock price of Versameb AG?
Versameb AG is a private company, so its shares have no public market price. Caplight tracks Versameb AG's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Versameb AG worth (valuation)?
Valuation information for Versameb AG is not publicly available.
Can I buy Versameb AG stock?
Versameb AG shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Versameb AG's last funding round?
Versameb AG's most recent funding round was VC Round on July 10, 2023.
Who are the main investors in Versameb AG?
Key investors in Versameb AG include BaseLaunch.
Will Versameb AG IPO soon?
No public IPO plans have been announced for Versameb AG.
How can I track Versameb AG secondary market activity?
Caplight tracks bids, offers, and trades in Versameb AG's shares on secondary markets.